Express Scripts Sues FTC Over Defamatory Report on Drug Prices

The lawsuit demands retraction of a report alleging that pharmacy benefit managers inflate drug costs and harm independent pharmacies.

Express Scripts, a subsidiary of The Cigna Group, filed the lawsuit in federal court in St. Louis, claiming the FTC's report is biased and defamatory.
The FTC's July 2024 report accused pharmacy benefit managers (PBMs) of driving up drug prices and squeezing independent pharmacies out of business.
Express Scripts argues that the report disregarded evidence provided by PBMs and followed ideological bias rather than sound economics.
The FTC stands by its findings, stating that three PBMs, including Express Scripts, control nearly 80% of the market and contribute to high drug costs.
The lawsuit also calls for FTC Chair Lina Khan to recuse herself from further actions against Express Scripts, citing alleged bias.